CLINICAL_TRIALS
trial_result
· 2023-04-28
Clinical Trial Update: A Study of LY3041658 in Adults With Hidradenitis Suppurativa [Phase 2]
Summary
Phase 2 clinical trial of LY3041658 in adults with hidradenitis suppurativa has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: COMPLETED | Results posted: 2023-04-28